These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24343233)

  • 1. Effect of TMEM106B polymorphism on functional network connectivity in asymptomatic GRN mutation carriers.
    Premi E; Formenti A; Gazzina S; Archetti S; Gasparotti R; Padovani A; Borroni B
    JAMA Neurol; 2014 Feb; 71(2):216-21. PubMed ID: 24343233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
    Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
    Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive reserve in granulin-related frontotemporal dementia: from preclinical to clinical stages.
    Premi E; Gazzina S; Bozzali M; Archetti S; Alberici A; Cercignani M; Bianchetti A; Gasparotti R; Turla M; Caltagirone C; Padovani A; Borroni B
    PLoS One; 2013; 8(9):e74762. PubMed ID: 24040338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.
    Cruchaga C; Graff C; Chiang HH; Wang J; Hinrichs AL; Spiegel N; Bertelsen S; Mayo K; Norton JB; Morris JC; Goate A
    Arch Neurol; 2011 May; 68(5):581-6. PubMed ID: 21220649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal FMRI resting-state functional connectivity in granulin mutations: the case of fronto-parietal dementia.
    Premi E; Cauda F; Gasparotti R; Diano M; Archetti S; Padovani A; Borroni B
    PLoS One; 2014; 9(9):e106500. PubMed ID: 25188321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD.
    Borroni B; Alberici A; Cercignani M; Premi E; Serra L; Cerini C; Cosseddu M; Pettenati C; Turla M; Archetti S; Gasparotti R; Caltagirone C; Padovani A; Bozzali M
    Neurobiol Aging; 2012 Oct; 33(10):2506-20. PubMed ID: 22130207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions.
    Lattante S; Le Ber I; Galimberti D; Serpente M; Rivaud-Péchoux S; Camuzat A; Clot F; Fenoglio C; ; Scarpini E; Brice A; Kabashi E
    Neurobiol Aging; 2014 Nov; 35(11):2658.e1-2658.e5. PubMed ID: 25085782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.
    Premi E; Grassi M; van Swieten J; Galimberti D; Graff C; Masellis M; Tartaglia C; Tagliavini F; Rowe JB; Laforce R; Finger E; Frisoni GB; de Mendonça A; Sorbi S; Gazzina S; Cosseddu M; Archetti S; Gasparotti R; Manes M; Alberici A; Cardoso MJ; Bocchetta M; Cash DM; Ourselin S; Padovani A; Rohrer JD; Borroni B;
    Brain; 2017 Jun; 140(6):1784-1791. PubMed ID: 28460069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia.
    Dopper EG; Rombouts SA; Jiskoot LC; den Heijer T; de Graaf JR; de Koning I; Hammerschlag AR; Seelaar H; Seeley WW; Veer IM; van Buchem MA; Rizzu P; van Swieten JC
    Neurology; 2014 Jul; 83(2):e19-26. PubMed ID: 25002573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional network connectivity in the behavioral variant of frontotemporal dementia.
    Filippi M; Agosta F; Scola E; Canu E; Magnani G; Marcone A; Valsasina P; Caso F; Copetti M; Comi G; Cappa SF; Falini A
    Cortex; 2013 Oct; 49(9):2389-401. PubMed ID: 23164495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
    Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
    J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.
    van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
    Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking for Neuroimaging Markers in Frontotemporal Lobar Degeneration Clinical Trials: A Multi-Voxel Pattern Analysis Study in Granulin Disease.
    Premi E; Cauda F; Costa T; Diano M; Gazzina S; Gualeni V; Alberici A; Archetti S; Magoni M; Gasparotti R; Padovani A; Borroni B
    J Alzheimers Dis; 2016; 51(1):249-62. PubMed ID: 26836150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study.
    Premi E; Giunta M; Iraji A; Rachakonda S; Calhoun VD; Gazzina S; Benussi A; Gasparotti R; Archetti S; Bocchetta M; Cash D; Todd E; Peakman G; Convery R; van Swieten JC; Jiskoot L; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Synofzik M; Galimberti D; Rowe JB; Masellis M; Tartaglia C; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Butler CR; Santana I; Gerhard A; Le Ber I; Pasquier F; Ducharme S; Levin J; Danek A; Sorbi S; Otto M; Rohrer JD; Borroni B;
    Neurobiol Aging; 2021 Dec; 108():155-167. PubMed ID: 34607248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.
    Galimberti D; Fumagalli GG; Fenoglio C; Cioffi SMG; Arighi A; Serpente M; Borroni B; Padovani A; Tagliavini F; Masellis M; Tartaglia MC; van Swieten J; Meeter L; Graff C; de Mendonça A; Bocchetta M; Rohrer JD; Scarpini E;
    Neurobiol Aging; 2018 Feb; 62():245.e9-245.e12. PubMed ID: 29146050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.
    Cabron AS; Borgmeyer U; Richter J; Peisker H; Gutbrod K; Dörmann P; Capell A; Damme M
    Acta Neuropathol Commun; 2023 Jan; 11(1):21. PubMed ID: 36707901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers.
    Moreno F; Sala-Llonch R; Barandiaran M; Sánchez-Valle R; Estanga A; Bartrés-Faz D; Sistiaga A; Alzualde A; Fernández E; Martí Massó JF; López de Munain A; Indakoetxea B
    Neurobiol Aging; 2013 May; 34(5):1462-8. PubMed ID: 23218900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies.
    Zhou X; Nicholson AM; Ren Y; Brooks M; Jiang P; Zuberi A; Phuoc HN; Perkerson RB; Matchett B; Parsons TM; Finch NA; Lin W; Qiao W; Castanedes-Casey M; Phillips V; Librero AL; Asmann Y; Bu G; Murray ME; Lutz C; Dickson DW; Rademakers R
    Brain; 2020 Jun; 143(6):1905-1919. PubMed ID: 32504082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.